Pathogenic Neisseria--interplay between pro- and eukaryotic worlds

. 1998 ; 43 (3) : 311-9.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid09717259

The pathogenic Neisseria species constitute a multi-faceted infection model of a highly adapted pathogen-host relationship. Several bacterial and host-cell factors involved in the cellular cross-talk have been recently unraveled. Using Neisseria gonorrhoeae as a prototype, several structurally variable surface proteins, including pili and Opa proteins, have been revealed as adhesins recognizing distinct host-cell receptors. The Opa proteins, in particular, are important in facilitating interaction with heparan sulfate proteoglycan receptors and members of the CD66 and integrin receptor families. These interactions not only enable the pathogens' anchoring, and penetration into, the human mucosa but also stimulate cellular signaling cascades involving the phosphatidylcholine-dependent phospholipase C, acidic sphingomyelinase and protein kinase C in epithelial cells, and Src-related kinases, Rac1, p21-activated kinase and Jun N-terminal kinase in phagocytic cells. Activation of these pathways is essential for the entry and intracellular accommodation of the pathogens but also leads to an early induction of cytokine release, thus priming the immune response. It is believed that detailed knowledge of cellular signaling cascades activated by infection will aid us in applying known and novel interfering drugs, in addition to classical antibiotic therapy, to the therapeutic and prophylactic treatment of persistent or otherwise difficult-to-treat bacterial infections.

Zobrazit více v PubMed

EMBO J. 1995 May 15;14(10):2144-54 PubMed

Mol Microbiol. 1996 Mar;19(6):1357-72 PubMed

J Clin Lab Anal. 1991;5(5):344-66 PubMed

FEBS Lett. 1998 Mar 6;424(1-2):84-8 PubMed

Cell. 1986 Jan 17;44(1):107-15 PubMed

Cell. 1986 Oct 10;47(1):61-71 PubMed

Mol Microbiol. 1996 Dec;22(5):941-50 PubMed

FASEB J. 1993 Aug;7(11):1023-30 PubMed

Mol Microbiol. 1996 Aug;21(3):433-40 PubMed

EMBO J. 1993 Nov;12(11):4043-51 PubMed

Nature. 1995 Jan 26;373(6512):357-9 PubMed

Infect Immun. 1997 Sep;65(9):3857-66 PubMed

FEBS Lett. 1997 Mar 17;405(1):86-90 PubMed

Cell. 1997 Nov 28;91(5):605-15 PubMed

J Exp Med. 1995 Aug 1;182(2):511-7 PubMed

Cell. 1996 May 3;85(3):391-402 PubMed

Nature. 1995 Nov 2;378(6552):32-8 PubMed

J Biol Chem. 1988 Jan 15;263(2):945-51 PubMed

J Infect Dis. 1996 Mar;173(3):636-46 PubMed

Mol Microbiol. 1997 Aug;25(4):639-47 PubMed

J Infect Dis. 1981 Mar;143(3):413-22 PubMed

Infect Immun. 1997 Aug;65(8):3391-8 PubMed

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14851-6 PubMed

Curr Top Microbiol Immunol. 1994;192:283-317 PubMed

Gene. 1997 Jun 11;192(1):125-34 PubMed

EMBO J. 1991 Jun;10(6):1307-15 PubMed

Infect Immun. 1996 Nov;64(11):4630-7 PubMed

Microbiol Mol Biol Rev. 1997 Jun;61(2):136-69 PubMed

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7986-90 PubMed

EMBO J. 1998 Jan 15;17(2):443-54 PubMed

EMBO J. 1997 Jun 16;16(12):3435-45 PubMed

EMBO J. 1993 Feb;12(2):641-50 PubMed

Annu Rev Microbiol. 1989;43:121-45 PubMed

Infect Immun. 1997 Jun;65(6):2353-61 PubMed

Annu Rev Cell Biol. 1991;7:275-310 PubMed

Infect Immun. 1997 Mar;65(3):964-70 PubMed

J Exp Med. 1997 Jul 21;186(2):247-58 PubMed

Infect Immun. 1997 May;65(5):1863-9 PubMed

Mol Microbiol. 1988 Mar;2(2):227-36 PubMed

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...